Close menu




February 3rd, 2021 | 09:18 CET

Evotec, GS Holdings, TUI - Growth without end!

  • Investments
Photo credits: pixabay.com

China's growth is almost uninterrupted. Experts predict that the Middle Kingdom will become the world's largest economy by 2028 at the latest. The fact that China has so far come out of the Corona Crisis in better shape means that the transition is likely to happen even sooner. The tiger economies such as Singapore, Hong Kong and Taiwan will also benefit. The upswing is giving rise to new business models with enormous growth potential for the coming years. We present the latest opportunities one by one.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: SG1CF0000001 , DE0005664809 , DE000TUAG000

Table of contents:


    Growing prosperity

    Due to the growth of the economies, the wages of the middle class are gradually increasing. This increase completely changes the lifestyle of the Asian population. Consumption is being boosted. The demand for foreign travel, wellness and health products is increasing. In addition, there is an increasing demand for new concepts in the catering and lifestyle industry. The system gastronomy sector is covered by the Singapore-based investment holding Company GS Holdings. The Company divides its business activities into two segments.

    The F&B Business segment comprises investments and the management of restaurants and cafés. In addition to management, new brands, concepts and franchise models are also developed here. GS currently operates three food courts in Bukit Batok and Sungei Kadut Way, a halal restaurant in Singapore and a famous chicken and rice restaurant under the "Sing Swee Kee" brand. In addition to Swing Swee Kee, the fast-growing "Raffles Coffee" brand is another drawing card in the franchise portfolio. "Raffles Coffee" is to be established in Asia similarly to the Starbucks brand, which is successful in the Western world.

    A new deal in the growth market

    Last week, Raffles Brands subsidiary inked a significant deal in the growth market of nutritional supplements with Kaifeng Jufeel. Raffles Brands will be appointed as the leading distributor for specific dietary supplements and related products derived from the aloe vera plant, as well as aloe vera-based food and beverage products. According to ResearchAndMarkets.com, China's dietary supplements market is expected to reach USD 40 billion by 2023, representing a compound annual growth rate of 14%.

    On two legs

    BOP is the second segment of GS Holdings. Its Wish Hospitality subsidiary handles branding, operations and services for the F&B and healthcare industries. This segment also coordinates training, staff recruitment and management functions. In addition to Singapore, the BOP division already operates in the Brunei, Malaysia and Indonesia markets. In addition to Singapore's primary market, the GS Holdings share can also be traded in Germany.

    Calm returns

    The drama seems to have come to an end, at least for Evotec's stock. After the Company entered the fairway last week between hedge fund Melvin Capital on one side and Robinhood traders on the other, the enormous fluctuations should now be over. According to reports in recent days, the US hedge fund now seems to have said goodbye to the share entirely. The hedge fund became known in the past few days for shorting Evotec shares and the US stock GameStop. In the US, a revolution of small investors is currently taking place who want to shake up large hedge funds. Melvin Capital held large short positions on the US stock GameStop, which were driven into extreme losses by a concerted buying campaign by small investors, fueled by the community "WallStreetBets" and coordinated via reddit.com.

    Major shareholder increases stake

    In the latest capital increase, major shareholder Alexei Mordashov increased his stake in tourism company TUI to 30.1%. Due to the exemption from BaFin, the major shareholder does not have to submit a takeover offer for the remaining shares in the Company, which is usually due when the 30% threshold is exceeded. The Corona Crisis has hit the Company particularly hard. The capital increase is part of a EUR 1.8 billion financing package agreed by TUI with Mordashov, the banks and the German government at the beginning of December.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Juliane Zielonka on December 1st, 2022 | 10:44 CET

    Aspermont, Twitter, Apple - Strong numbers, strong visions and marketplace power

    • Digitization
    • Commodities
    • Investments

    The Australian media company for the commodities industry has presented its latest figures. The results are impressive, with total revenue up 17% YOY, among other things. This industry pioneer illustrates just how valuable access to high-quality information can be. Perhaps soon to disappear from the scene is Elon Musk's Twitter: Find out how strong its dependence on the App Store giant is and what impact Apple fees may have on its revenue model here.

    Read

    Commented by Fabian Lorenz on November 30th, 2022 | 13:31 CET

    Biotech stocks in focus: Morphosys, Evotec, Bayer, BioNxt Solutions

    • Biotechnology
    • Cancer
    • Investments

    Biotech stocks have struggled in 2022. In Germany, BioNTech has overtaken the previous heavyweights Morphosys and Evotec in record time. Morphosys shocked investors with data on its Alzheimer's hope. Analysts lowered their thumbs, and short-sellers discovered the stock for themselves. Evotec has been quiet this year. Analysts think the valuation is attractive, but meeting earnings guidance in the current year is not a given. BioNxt shares have jumped recently, and if the positive newsflow continues into 2023, a re-rating is possible. At Bayer, the pharmaceuticals division is also developing positively. Conclusion: investors should position themselves for the biotech year 2023.

    Read

    Commented by Stefan Feulner on November 29th, 2022 | 13:32 CET

    Nvidia, Meta Materials, SFC Energy - Strong signs

    • Technology
    • Investments
    • nanotechnology

    After turbulent months on the technology stock markets with high markdowns, a bottoming out is taking place across the board. While many companies are reporting better-than-expected figures, investors are also buying oversold companies whose quarterly figures were below analysts' consensus. Due to the still high fluctuation range, high trading profits can be expected.

    Read